Effect of Flex-a-New on Osteoarthritis of the Knee

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2006 by Rabin Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Rabin Medical Center
ClinicalTrials.gov Identifier:
NCT00294801
First received: February 21, 2006
Last updated: NA
Last verified: February 2006
History: No changes posted
  Purpose

comparative trial of placebo versus flex-a-new (a food supplement) containing glucosamine an chondroitin sulfate for the symptom modification is knee osteoarthritis


Condition Intervention Phase
Osteoarthritis
Drug: flex-a-new (food supplement)
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by Rabin Medical Center:

Primary Outcome Measures:
  • KOOS

Secondary Outcome Measures:
  • VAS KSS

Estimated Enrollment: 80
Study Start Date: January 2006
Estimated Study Completion Date: December 2007
Detailed Description:

comparative trial of placebo versus flex-a-new (a food supplement) containing glucosamine an chondroitin sulfate for the symptom modification is knee osteoarthritis

  Eligibility

Ages Eligible for Study:   18 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

knee osteoarthritis grade 1 to 3 -

Exclusion Criteria:

ischemic heart disease with CHF -

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00294801

Locations
Israel
Rabin Medical Center Recruiting
Petah Tikwa, Israel, 49372
Contact: dror robinson, md    972-3-9372233    drorr@clalit.org.il   
Principal Investigator: dror robinson, md         
Sponsors and Collaborators
Rabin Medical Center
Investigators
Principal Investigator: dror robinson Rabin Medical Center
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00294801     History of Changes
Other Study ID Numbers: flex-a-new
Study First Received: February 21, 2006
Last Updated: February 21, 2006
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Rabin Medical Center:
knee osteoarthritis

Additional relevant MeSH terms:
Osteoarthritis
Osteoarthritis, Knee
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on October 19, 2014